Year In Review: 2016
2016 was a blockbuster year for the Vikor Group. Our specialist teams demonstrated yet again why we are the national leader in pharma distribution, sales and marketing, with Vikor Pharma delivering 13% above our targets and Vikor Enterprise delivering equally astonishing sales growth figures for our principals. It was a year marked with major milestones, with Vikor Healthcare receiving drug manufacturing licences and implementing several quality management programs.
It was also a year of expansion for us, with the Vikor Group companies collectively welcoming over 250 new team members, in addition to major capital investments including the addition of over 60 vehicles. We offer our sincere congratulations to all of the Vikor Teams for another year of surpassed targets – we wish you all a successful and healthy year as we head into the second quarter of 2017!